247 related articles for article (PubMed ID: 25024341)
1. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
4. Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.
Ariga T; Kubota M; Nakane M; Oguro K; Yu RK; Ando S
PLoS One; 2013; 8(5):e63326. PubMed ID: 23717411
[TBL] [Abstract][Full Text] [Related]
5. Results of testing for anti-GM1 antibodies.
McCombe PA; Wilson R; Prentice RL
J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
[TBL] [Abstract][Full Text] [Related]
6. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.
Kuijf ML; van Doorn PA; Tio-Gillen AP; Geleijns K; Ang CW; Hooijkaas H; Hop WC; Jacobs BC
J Neurol Sci; 2005 Dec; 239(1):37-44. PubMed ID: 16154154
[TBL] [Abstract][Full Text] [Related]
9. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
11. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
12. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
15. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
17. Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.
Cats EA; van der Pol WL; Tio-Gillen AP; Diekstra FP; van den Berg LH; Jacobs BC
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):502-4. PubMed ID: 25157033
[TBL] [Abstract][Full Text] [Related]
18. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
19. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.
Lardone RD; Alaniz ME; Irazoqui FJ; Nores GA
J Neuroimmunol; 2006 Apr; 173(1-2):174-9. PubMed ID: 16376437
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies to GM1 and GQ1b gangliosides].
Obayashi H; Fujinami A; Ohta M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():645-7. PubMed ID: 20942153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
